Given the numbers taking WLI in the UK, somewhere between 1 and 2 million people, the frequency and severity of rare side effects would seem to be incredibly low.
Strangely, the medication only continues to work if you continue to take it. Maintaining weight loss is a difficult challenge that as yet has no solution for the majority, other than continuing treatment with GLP1s. I am thrilled to be able to participate in the "field research" of these medications, to be able to use them to lose the weight and then to maintain that weight loss.